The abstract is read at the publisher; the summary is JClub's.
Circulating immune cell complexes—especially platelet-leukocyte aggregates and emerging T cell–monocyte complexes—are linked to inflammation and cardiometabolic risk in chronic states like HIV and metabolic dysfunction.
- Why it matters: Immune activation in cardiometabolic disease is often explained by soluble mediators or single-cell subset changes, leaving direct cell-cell organization less defined.
- What they did: The review synthesizes evidence for true immune-cell conjugates detected in blood or dissociated samples, emphasizing validated exclusion of technical doublets and contrasting established platelet-containing aggregates with fewer primary studies on non-platelet pairings.
- The result: It summarizes how these complexes appear regulated across acute infection and vaccination and persist in chronic inflammatory conditions, supporting their potential as biomarkers and therapeutic-response tools despite limited mechanistic and causal data.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.